Welcome to LookChem.com Sign In|Join Free
  • or
1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1093759-49-9

Post Buying Request

1093759-49-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1093759-49-9 Usage

Chemical compound

A chemical compound used as a building block in organic synthesis and medicinal chemistry.

Substituted pyridine derivative

It is a derivative of pyridine with a triisopropylsilyl group attached to the nitrogen atom.

Versatile intermediate

Known for its ability to serve as a versatile intermediate in the synthesis of various pharmaceuticals and agrochemicals.

Unique structure and reactivity

Its unique structure and reactivity make it a valuable tool for creating complex organic molecules.

Development of potential drug candidates

Utilized in the development of potential drug candidates and other bioactive compounds.

Protection for the nitrogen atom

The triisopropylsilyl group provides protection for the nitrogen atom, allowing for selective chemical transformations.

Enhanced stability

Enhances the compound's stability during chemical reactions due to the protective nature of the triisopropylsilyl group.

Check Digit Verification of cas no

The CAS Registry Mumber 1093759-49-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,3,7,5 and 9 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1093759-49:
(9*1)+(8*0)+(7*9)+(6*3)+(5*7)+(4*5)+(3*9)+(2*4)+(1*9)=189
189 % 10 = 9
So 1093759-49-9 is a valid CAS Registry Number.

1093759-49-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1093759-49-9 SDS

1093759-49-9Downstream Products

1093759-49-9Relevant academic research and scientific papers

Au-Catalyzed Cross-Coupling of Arenes via Double C-H Activation

Cambeiro, Xacobe C.,Ahlsten, Nanna,Larrosa, Igor

supporting information, p. 15636 - 15639 (2016/01/09)

The first methodology for Au(I/III)-catalyzed oxidative cross-coupling of arenes via double C-H activation has been developed. The reaction is fully selective for the cross-coupling between electron-rich hetero-/carbocyclic arenes and electron-poor arenes bearing relatively acidic C-H bonds. The inherently high cross-selectivity of the system obviates the need for directing groups or a large excess of one of the coupling partners.

A closer look at the bromine-lithium exchange with tert-butyllithium in an aryl sulfonamide synthesis

Waldmann, Christopher,Schober, Otmar,Haufe, Guenter,Kopka, Klaus

, p. 2954 - 2957 (2013/07/26)

A practical protocol for the one-pot synthesis of various aryl sulfonamides, notably of pyridine-core-substituted 7-azaindolyl sulfonamides, is described. A key step is the well-known bromine-lithium exchange reaction of an aryl bromide with tert-butyllithium (t-BuLi). Differing from the common practice to use 2 or more equiv of organolithium, the exact amount of t-BuLi needed for a sufficient exchange reaction is determined for each aryl bromide in a GC-MS-assisted experiment.

AZAINDOLES USEFUL AS INHIBITORS OF ROCK AND OTHER PROTEIN KINASES

-

Page/Page column 180-189, (2008/06/13)

The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1093759-49-9